| CDC34 |
P49427
|
cell division cycle 34
|
|
0.96 |
0.705 |
0.308 |
| CDK4 |
P11802
|
cyclin dependent kinase 4
|
Kinase
|
6.3E-02 |
0.412 |
0.808 |
| CDKN2A |
P42771 Q8N726
|
cyclin dependent kinase inhibitor 2A
|
|
0.39 |
0.300 |
0.885 |
| CDKN2B |
P42772
|
cyclin dependent kinase inhibitor 2B
|
|
7.3E-03 |
0.417 |
0.769 |
| CDKN3 |
Q16667
|
cyclin dependent kinase inhibitor 3
|
|
1.9E-03 |
0.514 |
0.769 |
| CRLF2 |
Q9HC73
|
cytokine receptor like factor 2
|
Signaling
|
3.3E-07 |
0.615 |
0.538 |
| CSF2 |
P04141
|
colony stimulating factor 2
|
Signaling
|
0.83 |
0.330 |
0.962 |
| CTNNB1 |
P35222
|
catenin beta 1
|
|
1.00 |
0.303 |
0.885 |
| CYLD |
Q9NQC7
|
CYLD lysine 63 deubiquitinase
|
Enzyme
|
1.00 |
0.498 |
0.846 |
| DLL1 |
O00548
|
delta like canonical Notch ligand 1
|
|
1.00 |
0.492 |
0.808 |
| DLL4 |
Q9NR61
|
delta like canonical Notch ligand 4
|
|
1.00 |
0.494 |
0.769 |
| DNMT3A |
Q9Y6K1
|
DNA methyltransferase 3 alpha
|
|
7.4E-39 |
0.445 |
0.846 |
| DUSP1 |
P28562
|
dual specificity phosphatase 1
|
|
1.0E-02 |
0.491 |
0.808 |
| ETV6 |
P41212
|
ETS variant transcription factor 6
|
Transcription factor
|
0.97 |
0.477 |
0.731 |
| FANCD2 |
Q9BXW9
|
FA complementation group D2
|
|
1.1E-30 |
0.479 |
0.885 |
| FBXW7 |
Q969H0
|
F-box and WD repeat domain containing 7
|
Enzyme modulator
|
1.00 |
0.465 |
0.808 |
| FCER2 |
P06734
|
Fc fragment of IgE receptor II
|
Receptor
|
7.6E-12 |
0.560 |
0.654 |
| FGF23 |
Q9GZV9
|
fibroblast growth factor 23
|
Signaling
|
3.1E-02 |
0.460 |
0.731 |
| FLT3 |
P36888
|
fms related receptor tyrosine kinase 3
|
Kinase
|
0.61 |
0.462 |
0.654 |
| FOXO3 |
O43524
|
forkhead box O3
|
|
0.99 |
0.431 |
0.808 |
| H3P10 |
|
H3 histone pseudogene 10
|
|
|
0.350 |
0.846 |
| H3P9 |
|
H3 histone pseudogene 9
|
|
|
0.505 |
0.731 |
| HES1 |
Q14469
|
hes family bHLH transcription factor 1
|
Transcription factor
|
0.71 |
0.468 |
0.885 |
| HLA-G |
P17693
|
major histocompatibility complex, class I, G
|
|
1.4E-11 |
0.461 |
0.769 |
| IFNG |
P01579
|
interferon gamma
|
|
0.47 |
0.288 |
0.962 |